CYCLOPHARM LIMITED — Director's Dealing 2019

Apr 2, 2019

3 April 2019

Australian Securities Exchange Limited 20 Bridge Street Sydney NSW 2000

==> picture [43 x 55] intentionally omitted <==

cyclo pharm

cyclo medica techne gas ultra lute Cyclopharm Ltd ABN 74 116 931 250 Unit 4, 1 The Crescent Kingsgrove NSW 2208 Australia T 61 2 9541 0411 F 61 2 9543 0960 www.cyclopharm.com.au

Dear Sir/Madam,

Cyclopharm Limited (“Company”) Appendix 3Y – Change of Directors Interests

I refer to the Company’s Appendix 3Y letter dated today which accompanies this letter and advise as follows:

• 1 . 19,412 shares purchased by an entity indirectly associated with Mr Gould was not reported to the Company due to administrative oversight and was uncovered during a review of Directors’ interests in the Company.

• To ensure compliance with its disclosure requirements, the Company has in place a Continuous Disclosure and Market Communication Policy requiring all directors and staff to report to the Company all information required to be disclosed to the ASX. The directors are required to notify the Company of changes in their direct and indirect shareholdings as soon as they become aware of the transaction occurring.

• The Company is satisfied that the current processes to ensure compliance with disclosure obligations under ASX Listing Rule 3.19A are in place but will regularly remind all directors of their disclosure obligations to ensure reporting in a timely manner.

Yours faithfully Cyclopharm Limited

==> picture [110 x 29] intentionally omitted <==

James McBrayer

Managing Director and Company Secretary +612 9541 0411

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CYCLOPHARM LIMITED

ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Vanda Russell Gould
Date of last notice	17/09/2018

c

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	French Park Investments Pty Ltd (director) French Park Investments Pty Ltd (Shean Family Super Fund A/c) (director) Mrs Debbie Anne Gould (spouse) Leagou Pty Limited (director) Malackey Holdings Pty Ltd (alternate director) Melbourne Corp of Australia Pty Ltd (director) Melbourne Corporation of Australia Pty Ltd (Superannuation Fund A/c) (director) South Seas Holdings Pty Limited (director) Chemical Trustee Limited (related party*)
Date of change	28/2/2019 and 7/3/2019

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	French Park Investments Pty Ltd 69,660 French Park Investments Pty Ltd (Shean Family Super Fund A/c) 160,588 Mrs Debbie Anne Gould 6,000 Leagou Pty Limited 6,000 Malackey Holdings Pty Ltd 720,220 Melbourne Corp of Australia Pty Ltd 400,000 Melbourne Corporation of Australia Pty Ltd (Superannuation Fund A/c) 1,027,376 South Seas Holdings Pty Limited 675,000 Chemical Trustee Limited (related party) 9,176,470 Total shares 12,241,314*
Class	Ordinary Shares
Number acquired	19,412
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$24,339.62
No. of securities held after change	French Park Investments Pty Ltd 69,660 French Park Investments Pty Ltd (Shean Family Super Fund A/c) 180,000 Mrs Debbie Anne Gould 6,000 Leagou Pty Limited 6,000 Malackey Holdings Pty Ltd 720,220 Melbourne Corp of Australia Pty Ltd 400,000 Melbourne Corporation of Australia Pty Ltd (Superannuation Fund A/c) 1,027,376 South Seas Holdings Pty Limited 675,000 Chemical Trustee Limited (related party) 9,176,470 Total shares 12,260,726*
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Acquisition - On-market trade Note (*) : On 25 November 2016, Mr Gould notified the market that despite the fact that he believed he did not have the requisite control to constitute relevant interests in Chemical Trustee Limited, as an advisor to this entity, he had declared a relevant interest in those shares.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Nil
Nature of interest	Nil
Name of registered holder (if issued securities)	Nil
Date of change	Nil
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	Nil
Interest acquired	Nil
Interest disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Nil
Interest after change	Nil

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not Applicable
If prior written clearance was provided, on what date was this provided?	Not Applicable

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3